JSPR
#4612
Jasper Therapeutics, Inc. - Class A Common Stock
0.7 2 USD
+0.18%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+18.03%
Monthly Change
+53.19%
6 month change
-52.32%
Year Change
-78.57%
Previous Close
0.6 1
Open
0.7 2
Low
0.7 2
High
0.7 2
Volume
3
Financials
- Market Capitalization 20.16 M
- Employee 22
- Founded 2018
- CEO N/A
- Website www.jaspertherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QPZNP97
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4596 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 5.02 USD | +0.40% | -11.78% | -49.50% | +311.48% | 21.02 M USD | ||
| 4597 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 2.63 USD | 0.00% | -2.59% | +11.91% | -16.24% | 21.02 M USD | ||
| 4624 |  ATOS Atossa Therapeutics, Inc. - Common Stock | 2.26 USD | -5.83% | -9.96% | -4.24% | +148.35% | 19.46 M USD | ||
| 4625 |  LGVN Longeveron Inc. - Class A Common stock | 0.62 USD | -1.59% | -3.13% | -21.52% | +8.52% | 19.31 M USD |
Frequently asked questions about Jasper Therapeutics, Inc. - Class A Common Stock
What is the Jasper Therapeutics, Inc. - Class A Common Stock stock price today?
The current price of Jasper Therapeutics, Inc. - Class A Common Stock (JSPR) is 0.72. Over the past 24 hours, the stock has changed by +18.03%. Follow the JSPR chart for real-time price dynamics.
What is the stock ticker of Jasper Therapeutics, Inc. - Class A Common Stock?
Jasper Therapeutics, Inc. - Class A Common Stock trades under the ticker JSPR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Jasper Therapeutics, Inc. - Class A Common Stock stock going up?
JSPR has changed by +50.00% over the last week, +53.19% over the last month, and -78.57% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Jasper Therapeutics, Inc. - Class A Common Stock net income for the last quarter?
Jasper Therapeutics, Inc. - Class A Common Stock reported net income of -1.17 M for the last quarter. The previous quarter showed -9.1 M, which means net income changed by +87.10%.
How many employees does Jasper Therapeutics, Inc. - Class A Common Stock have?
As of the latest available data, Jasper Therapeutics, Inc. - Class A Common Stock has 22 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Jasper Therapeutics, Inc. - Class A Common Stock stock?
You can buy Jasper Therapeutics, Inc. - Class A Common Stock (JSPR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Jasper Therapeutics, Inc. - Class A Common Stock stock?
Investing in Jasper Therapeutics, Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the JSPR chart and related analysis on metatrader.com as part of your research.